163 related articles for article (PubMed ID: 12192539)
1. Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21.
Maleno I; López-Nevot MA; Cabrera T; Salinero J; Garrido F
Cancer Immunol Immunother; 2002 Sep; 51(7):389-96. PubMed ID: 12192539
[TBL] [Abstract][Full Text] [Related]
2. Distribution of HLA class I altered phenotypes in colorectal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21.
Maleno I; Cabrera CM; Cabrera T; Paco L; López-Nevot MA; Collado A; Ferrón A; Garrido F
Immunogenetics; 2004 Jul; 56(4):244-53. PubMed ID: 15258706
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity at 6p21 underlying [corrected] HLA class I downregulation in Chinese primary esophageal squamous cell carcinomas.
Yang Y; Zhang J; Miao F; Wei J; Shen C; Shen Y; Xie W
Tissue Antigens; 2008 Aug; 72(2):105-14. PubMed ID: 18721270
[TBL] [Abstract][Full Text] [Related]
4. Low frequency of HLA haplotype loss associated with loss of heterozygocity in chromosome region 6p21 in clear renal cell carcinomas.
Maleno I; Lopez Nevot MA; Seliger B; Garrido F
Int J Cancer; 2004 Apr; 109(4):636-8. PubMed ID: 14991587
[TBL] [Abstract][Full Text] [Related]
5. Molecular strategies to define HLA haplotype loss in microdissected tumor cells.
Ramal LM; Maleno I; Cabrera T; Collado A; Ferron A; Lopez-Nevot MA; Garrido F
Hum Immunol; 2000 Oct; 61(10):1001-12. PubMed ID: 11082513
[TBL] [Abstract][Full Text] [Related]
6. LOH at 6p21.3 region and HLA class I altered phenotypes in bladder carcinomas.
Maleno I; Romero JM; Cabrera T; Paco L; Aptsiauri N; Cozar JM; Tallada M; López-Nevot MA; Garrido F
Immunogenetics; 2006 Jul; 58(7):503-10. PubMed ID: 16705407
[TBL] [Abstract][Full Text] [Related]
7. HLA class I alterations in breast carcinoma are associated with a high frequency of the loss of heterozygosity at chromosomes 6 and 15.
Garrido MA; Rodriguez T; Zinchenko S; Maleno I; Ruiz-Cabello F; Concha Á; Olea N; Garrido F; Aptsiauri N
Immunogenetics; 2018 Nov; 70(10):647-659. PubMed ID: 30145665
[TBL] [Abstract][Full Text] [Related]
8. HLA class I expression and chromosomal deletions at 6p and 15q in head and neck squamous cell carcinomas.
Feenstra M; Veltkamp M; van Kuik J; Wiertsema S; Slootweg P; van den Tweel J; de Weger R; Tilanus M
Tissue Antigens; 1999 Sep; 54(3):235-45. PubMed ID: 10519360
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity at 6p21 and HLA class I expression in esophageal squamous cell carcinomas in China.
Zhao X; Sun Q; Tian H; Cong B; Jiang X; Peng C
Asian Pac J Cancer Prev; 2011; 12(10):2741-5. PubMed ID: 22320985
[TBL] [Abstract][Full Text] [Related]
10. Microsatellite instability analysis in tumors with different mechanisms for total loss of HLA expression.
Jimenez P; Cantón J; Concha A; Cabrera T; Fernández M; Real LM; García A; Serrano A; Garrido F; Ruiz-Cabello F
Cancer Immunol Immunother; 2000 Mar; 48(12):684-90. PubMed ID: 10752476
[TBL] [Abstract][Full Text] [Related]
11. High frequency of homozygosity of the HLA region in melanoma cell lines reveals a pattern compatible with extensive loss of heterozygosity.
Rodriguez T; Méndez R; Roberts CH; Ruiz-Cabello F; Dodi IA; López Nevot MA; Paco L; Maleno I; Marsh SG; Pawelec G; Garrido F
Cancer Immunol Immunother; 2005 Feb; 54(2):141-8. PubMed ID: 15592718
[TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity at 6p21.3 underlying HLA class I downregulation in gastric cancer.
Wang XC; Zhang JQ; Shen YQ; Miao FQ; Xie W
J Exp Clin Cancer Res; 2006 Mar; 25(1):115-9. PubMed ID: 16761627
[TBL] [Abstract][Full Text] [Related]
13. Microsatellite analysis of microdissected tumor cells and 6p high density microsatellite analysis in head and neck squamous cell carcinomas with down-regulated human leukocyte antigen class I expression.
Feenstra M; Verdaasdonk M; van der Zwan AW; de Weger R; Slootweg P; Tilanus M
Lab Invest; 2000 Mar; 80(3):405-14. PubMed ID: 10744076
[TBL] [Abstract][Full Text] [Related]
14. High frequency of altered HLA class I phenotypes in laryngeal carcinomas.
Cabrera T; Salinero J; Fernandez MA; Garrido A; Esquivias J; Garrido F
Hum Immunol; 2000 May; 61(5):499-506. PubMed ID: 10773352
[TBL] [Abstract][Full Text] [Related]
15. Frequent loss of heterozygosity in the β2-microglobulin region of chromosome 15 in primary human tumors.
Maleno I; Aptsiauri N; Cabrera T; Gallego A; Paschen A; López-Nevot MA; Garrido F
Immunogenetics; 2011 Feb; 63(2):65-71. PubMed ID: 21086121
[TBL] [Abstract][Full Text] [Related]
16. Analysis of HLA expression in human tumor tissues.
Cabrera T; López-Nevot MA; Gaforio JJ; Ruiz-Cabello F; Garrido F
Cancer Immunol Immunother; 2003 Jan; 52(1):1-9. PubMed ID: 12536234
[TBL] [Abstract][Full Text] [Related]
17. High level of aneuploidy of chromosome 6 by FISH analysis of head and neck squamous cell carcinoma: limited applicability of LOH analysis to define HLA loss.
Koene GJ; Arts-Hilkes YH; van Dijk AJ; van der Ven KJ; Slootweg PJ; de Weger RA; Tilanus MG
Hum Immunol; 2004 Dec; 65(12):1455-62. PubMed ID: 15603873
[TBL] [Abstract][Full Text] [Related]
18. Chromosome loss is the most frequent mechanism contributing to HLA haplotype loss in human tumors.
Jiménez P; Cantón J; Collado A; Cabrera T; Serrano A; Real LM; García A; Ruiz-Cabello F; Garrido F
Int J Cancer; 1999 Sep; 83(1):91-7. PubMed ID: 10449614
[TBL] [Abstract][Full Text] [Related]
19. Frequency and genetic basis of MHC, beta-2-microglobulin and MEMO-1 loss of heterozygosity in sporadic breast cancer.
McEvoy CR; Seshadri R; Morley AA; Firgaira FA
Tissue Antigens; 2002 Sep; 60(3):235-43. PubMed ID: 12445306
[TBL] [Abstract][Full Text] [Related]
20. DNA hypermethylation is a mechanism for loss of expression of the HLA class I genes in human esophageal squamous cell carcinomas.
Nie Y; Yang G; Song Y; Zhao X; So C; Liao J; Wang LD; Yang CS
Carcinogenesis; 2001 Oct; 22(10):1615-23. PubMed ID: 11577000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]